BNP and congestive heart failure

被引:252
作者
Cowie, MR
Mendez, GF
机构
[1] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London, England
[2] Natl Med Ctr, Inst Mexicano Seguro Social, Cardiol Hosp Siglo XXI, Mexico City, DF, Mexico
关键词
D O I
10.1053/pcad.2002.24599
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Brain natriuretic peptide (BNP), a peptide hormone secreted chiefly by ventricular myocytes, plays a key role in volume homeostasis. The plasma concentration of BNP is raised in various pathological states, especially heart failure. Many studies suggest that measurement of plasma BNP has clinical utility for excluding a diagnosis of heart failure in patients with dyspnea or fluid retention and for providing prognostic information in those with heart failure or other cardiac disease. It may also be of value in identifying patients after myocardial infarction in whom further assessment of cardiac function is likely to be worthwhile. Preliminary evidence suggests that measuring the plasma concentration of BNP may be useful in fine tuning therapy for heart failure. Artificially raising the circulating levels of BNP shows considerable promise as a treatment for heart failure. With simpler assay methods now available, it is likely that many physicians will measure plasma BNP to aid them in the diagnosis, risk stratification, and monitoring of their patients with heart failure or other cardiac dysfunction. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:293 / 321
页数:29
相关论文
共 231 条
[41]   Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction [J].
Darbar, D ;
Davidson, NC ;
Gillespie, N ;
Choy, AMJ ;
Lang, CC ;
Shyr, Y ;
McNeill, GP ;
Pringle, TH ;
Struthers, AD .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (03) :284-287
[42]   Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction [J].
Davidson, NC ;
Naas, AA ;
Hanson, JK ;
Kennedy, NSJ ;
Coutie, WJ ;
Struthers, AD .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (10) :828-831
[43]  
DAVIDSON NC, 1995, CIRCULATION, V91, P1276
[44]   ATRIAL-NATRIURETIC-PEPTIDE LEVELS IN THE PREDICTION OF CONGESTIVE-HEART-FAILURE RISK IN FRAIL ELDERLY [J].
DAVIS, KM ;
FISH, LC ;
ELAHI, D ;
CLARK, BA ;
MINAKER, KL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (19) :2625-2629
[45]   PLASMA BRAIN NATRIURETIC PEPTIDE IN ASSESSMENT OF ACUTE DYSPNEA [J].
DAVIS, M ;
ESPINER, E ;
RICHARDS, G ;
BILLINGS, J ;
TOWN, I ;
NEILL, A ;
DRENNAN, C ;
RICHARDS, M ;
TURNER, J ;
YANDLE, T .
LANCET, 1994, 343 (8895) :440-444
[46]   Mechanical and neuroendocrine regulation of the endocrine heart [J].
deBold, AJ ;
Bruneau, BG ;
deBold, MLK .
CARDIOVASCULAR RESEARCH, 1996, 31 (01) :7-18
[47]   A RAPID AND POTENT NATRIURETIC RESPONSE TO INTRAVENOUS-INJECTION OF ATRIAL MYOCARDIAL EXTRACT IN RATS [J].
DEBOLD, AJ ;
BORENSTEIN, HB ;
VERESS, AT ;
SONNENBERG, H .
LIFE SCIENCES, 1981, 28 (01) :89-94
[48]   Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro:: implications for assessment of left ventricular dysfunction [J].
Downie, PF ;
Talwar, S ;
Squire, IB ;
Davies, JE ;
Barnett, DB ;
Ng, LL .
CLINICAL SCIENCE, 1999, 97 (03) :255-258
[49]   Expression and distribution of brain natriuretic peptide in human right atria [J].
Doyama, K ;
Fukumoto, M ;
Takemura, G ;
Tanaka, M ;
Oda, T ;
Hasegawa, K ;
Inada, T ;
Ohtani, S ;
Fujiwara, T ;
Itoh, H ;
Nakao, K ;
Sasayama, S ;
Fujiwara, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1832-1838
[50]  
Durocher D, 1998, RECENT PROG HORM RES, V53, P7